Episode 16: Dr. Alex Adjei, Scientific Advisory Board Member at Biorasi

Episode 16 December 15, 2021 00:58:27
Episode 16: Dr. Alex Adjei, Scientific Advisory Board Member at Biorasi
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 16: Dr. Alex Adjei, Scientific Advisory Board Member at Biorasi

Dec 15 2021 | 00:58:27

/

Show Notes

Welcome to a special epsiode of Few & Far Between. Our guest this week is oncologist Dr. Alex Adjei, Scientific Advisory Board Member at Biorasi, and Professor of Oncology and Pharmacology at the Mayo Clinic and Mayo College of Medicine in Rochester, Minnesota. Join our host, Dr. Dipali Patel, for an in-depth discussion on lung cancer - an urgent, global disease that requires empathy and understanding.

Other Episodes

Episode 5

July 07, 2021 00:51:14
Episode Cover

Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development...

Listen

Episode 9

September 01, 2021 00:47:27
Episode Cover

Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP

Tune in for today's full episode of Few & Far Between. Episode 9 features Biorasi's Becky Knockemus, Zogenix, Inc.'s Dawn Blessing, and J. Michael...

Listen

Episode 36

December 05, 2023 00:51:43
Episode Cover

Episode 36: Zak Kohane, Department of Biomedical Informatics at Harvard Medical School

"Patients have already been exposed to these large language models (LLMs). Yes, they are aware of the risks, but they are also very aware...

Listen